Sensei Biotherapeutics Ownership | Who Owns Sensei Biotherapeutics?


OverviewFinancialsChart

Sensei Biotherapeutics Ownership Summary


Sensei Biotherapeutics is owned by 9.34% institutional investors, 34.31% insiders, and 56.36% retail investors. Ikarian capital is the largest institutional shareholder, holding 2.58% of SNSE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.93% of its assets in Sensei Biotherapeutics shares.

SNSE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSensei Biotherapeutics9.34%34.31%56.36%
SectorHealthcare Stocks 57.47%9.40%33.13%
IndustryBiotech Stocks 69.06%8.93%22.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ikarian capital649.96K2.58%$318.55K
Vanguard group594.45K2.36%$291.28K
Boothbay fund management172.80K0.69%$84.69K
Renaissance156.80K0.62%$76.85K
Geode capital management148.89K0.59%$72.99K
Xtx topco62.90K0.25%$30.83K
Bridgeway capital management47.90K0.19%$23.48K
Susquehanna group, llp38.05K0.15%$18.65K
Northern trust25.98K0.10%$16.11K
State street25.77K0.10%$12.63K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital649.96K0.04%$318.55K
Deuterium capital management11.00K0.01%$5.39K
Xtx topco62.90K0.00%$30.83K
Boothbay fund management172.80K0.00%$84.69K
Bridgeway capital management47.90K0.00%$23.48K
Renaissance156.80K0.00%$76.85K
Tower research capital llc (trc)5.45K0.00%$2.67K
Two sigma securities---
Two sigma investments, lp---
Two sigma advisers, lp---

Top Buyers

HolderShares% AssetsChange
Xtx topco62.90K0.00%48.98K
Raymond james financial14.00K-14.00K
Hrt financial lp11.60K-11.60K
Bnp paribas arbitrage, snc160.00-160.00
Ubs group2.00-2.00

Top Sellers

HolderShares% AssetsChange
Newtyn management---930.23K
Bank of america corp /de/139.00--90.62K
Renaissance156.80K0.00%-58.77K
Susquehanna group, llp38.05K--52.38K
National bank of canada /fi/---45.58K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial14.00K-14.00K$6.86K
Hrt financial lp11.60K-11.60K$5.00K
Bnp paribas arbitrage, snc160.00-160.00$78.00
Ubs group2.00-2.00$1.00

Sold Out

HolderChange
Qube research-4.00
Wells fargo & company/mn-133.00
Banque cantonale vaudoise-3.90K
Two sigma investments, lp-10.18K
Leo wealth-14.85K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20242321.05%2,347,6166.38%912.08%740.00%11120.00%
Sep 30, 202419-17.39%2,206,8174.71%812.42%5-50.00%5-
Jun 30, 202423-4.17%2,107,576-8.74%812.33%1066.67%5-16.67%
Mar 31, 2024244.35%2,309,379-22.04%86.13%620.00%6-
Dec 31, 2023234.55%2,962,310-4.73%1111.18%566.67%6-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv485.96K1.93%-
Vanguard Institutional Extnd Mkt Idx Tr99.62K0.40%-
Fidelity Extended Market Index89.13K0.35%-718.00
Bridgeway Ultra-Small Company Market47.90K0.19%-
Fidelity Total Market Index28.33K0.11%-
Northern Trust Extended Eq Market Idx17.92K0.07%-
NT Ext Equity Mkt Idx Fd - L17.92K0.07%-
Fidelity Series Total Market Index17.48K0.07%-
Vanguard Instl Ttl Stck Mkt Idx Tr15.07K0.06%-
Quint:Essence Strat Social Media&Tech P10.00K0.04%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 2023Celebi John President and CEOBuy$425.00
Jun 01, 2023Apeiron Investment Group Ltd.-Sell$1.51M
Feb 23, 2023Apeiron Investment Group Ltd.-Buy$1.76K
Feb 23, 2023Apeiron Investment Group Ltd.-Buy$1.78K
Mar 02, 2022Peyer James Buy$3.85K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

SNSE Ownership FAQ


Who Owns Sensei Biotherapeutics?

Sensei Biotherapeutics shareholders are primarily institutional investors at 9.34%, followed by 34.31% insiders and 56.35% retail investors. The average institutional ownership in Sensei Biotherapeutics's industry, Biotech Stocks , is 69.06%, which Sensei Biotherapeutics falls below.

Who owns the most shares of Sensei Biotherapeutics?

Sensei Biotherapeutics’s largest shareholders are Ikarian capital (649.96K shares, 2.58%), Vanguard group (594.45K shares, 2.36%), and Boothbay fund management (172.8K shares, 0.69%). Together, they hold 5.64% of Sensei Biotherapeutics’s total shares outstanding.

Does Blackrock own Sensei Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Sensei Biotherapeutics.

Who is Sensei Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Sensei Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 649.96K Sensei Biotherapeutics shares, valued at 318.55K$.

Who is the top mutual fund holder of Sensei Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Sensei Biotherapeutics shares, with 1.93% of its total shares outstanding invested in 485.96K Sensei Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools